Compensation award — excluded from discretionary-purchase analysis.
Traded Dec 4, 2025 · Filed Dec 9, 2025
Ovintiv's & COO sold $2.13M of Ovintiv shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$2,125,000
Shares × reported transaction price
30 days after results of Nov 4, 2025, 81 days before results of Feb 23, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −10.0% | −0.6% | −9.4% |
| 30 days | −6.6% | +0.9% | −7.6% |
| 90 days | +29.7% | −0.7% | +30.4% |
| 180 days | +39.8% | +8.2% | +31.6% |
Past results only. Not a forecast.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.